NO20063997L - Tablett med flere lag - Google Patents
Tablett med flere lagInfo
- Publication number
- NO20063997L NO20063997L NO20063997A NO20063997A NO20063997L NO 20063997 L NO20063997 L NO 20063997L NO 20063997 A NO20063997 A NO 20063997A NO 20063997 A NO20063997 A NO 20063997A NO 20063997 L NO20063997 L NO 20063997L
- Authority
- NO
- Norway
- Prior art keywords
- immediate release
- layer formulated
- multilayer tablet
- diuretic
- optionally
- Prior art date
Links
- 239000012729 immediate-release (IR) formulation Substances 0.000 abstract 3
- 239000011159 matrix material Substances 0.000 abstract 3
- 239000003826 tablet Substances 0.000 abstract 3
- 239000002934 diuretic Substances 0.000 abstract 2
- 230000001882 diuretic effect Effects 0.000 abstract 2
- RMMXLENWKUUMAY-UHFFFAOYSA-N telmisartan Chemical compound CCCC1=NC2=C(C)C=C(C=3N(C4=CC=CC=C4N=3)C)C=C2N1CC(C=C1)=CC=C1C1=CC=CC=C1C(O)=O RMMXLENWKUUMAY-UHFFFAOYSA-N 0.000 abstract 2
- 239000005541 ACE inhibitor Substances 0.000 abstract 1
- 101710129690 Angiotensin-converting enzyme inhibitor Proteins 0.000 abstract 1
- 101710086378 Bradykinin-potentiating and C-type natriuretic peptides Proteins 0.000 abstract 1
- 239000005537 C09CA07 - Telmisartan Substances 0.000 abstract 1
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 abstract 1
- 239000002333 angiotensin II receptor antagonist Substances 0.000 abstract 1
- 229940126317 angiotensin II receptor antagonist Drugs 0.000 abstract 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 abstract 1
- 229960002003 hydrochlorothiazide Drugs 0.000 abstract 1
- HDACQVRGBOVJII-JBDAPHQKSA-N ramipril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](C[C@@H]2CCC[C@@H]21)C(O)=O)CC1=CC=CC=C1 HDACQVRGBOVJII-JBDAPHQKSA-N 0.000 abstract 1
- 229960003401 ramipril Drugs 0.000 abstract 1
- 239000007944 soluble tablet Substances 0.000 abstract 1
- 229960005187 telmisartan Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B30—PRESSES
- B30B—PRESSES IN GENERAL
- B30B11/00—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses
- B30B11/02—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses using a ram exerting pressure on the material in a moulding space
- B30B11/08—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses using a ram exerting pressure on the material in a moulding space co-operating with moulds carried by a turntable
- B30B11/085—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses using a ram exerting pressure on the material in a moulding space co-operating with moulds carried by a turntable for multi-layer articles
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Mechanical Engineering (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004008804A DE102004008804A1 (de) | 2004-02-20 | 2004-02-20 | Mehrschichttablette |
| PCT/EP2005/001498 WO2005079762A1 (en) | 2004-02-20 | 2005-02-15 | Multilayer tablet |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20063997L true NO20063997L (no) | 2006-11-14 |
Family
ID=34832975
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20063997A NO20063997L (no) | 2004-02-20 | 2006-09-06 | Tablett med flere lag |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20050186274A1 (es) |
| EP (1) | EP1718281A1 (es) |
| JP (1) | JP2007523112A (es) |
| KR (1) | KR20060130671A (es) |
| CN (1) | CN1921840A (es) |
| AR (1) | AR047806A1 (es) |
| AU (1) | AU2005215115A1 (es) |
| BR (1) | BRPI0507887A (es) |
| CA (1) | CA2552902A1 (es) |
| DE (1) | DE102004008804A1 (es) |
| EC (1) | ECSP066779A (es) |
| IL (1) | IL177536A0 (es) |
| MX (1) | MXPA06008225A (es) |
| NO (1) | NO20063997L (es) |
| PE (1) | PE20051127A1 (es) |
| RU (1) | RU2006133453A (es) |
| TW (1) | TW200533389A (es) |
| UY (1) | UY28753A1 (es) |
| WO (1) | WO2005079762A1 (es) |
| ZA (1) | ZA200604913B (es) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080234353A1 (en) * | 2004-03-24 | 2008-09-25 | Reynir Eyjolfsson | Formulations of Ramipril |
| GB0518129D0 (en) * | 2005-09-06 | 2005-10-12 | Arrow Int Ltd | Ramipril formulation |
| US20070098782A1 (en) * | 2005-10-28 | 2007-05-03 | Selamine Limited | Ramipril Formulation |
| GB2431579A (en) * | 2005-10-28 | 2007-05-02 | Arrow Int Ltd | Ramipril formulations |
| US8637078B2 (en) * | 2005-11-24 | 2014-01-28 | Boehringer Ingelheim International Gmbh | Bilayer tablet comprising telmisartan and diuretic |
| CA2642761A1 (en) * | 2006-02-23 | 2007-08-30 | Iomedix Sleep International Srl | Compositions and methods for the induction and maintenance of quality sleep |
| US8685452B2 (en) * | 2006-06-16 | 2014-04-01 | Lek Pharmaceuticals D.D. | Pharmaceutical composition |
| WO2008001184A2 (en) * | 2006-06-26 | 2008-01-03 | Emcure Pharmaceuticals Limited | Solid composition |
| EP1908469A1 (en) | 2006-10-06 | 2008-04-09 | Boehringer Ingelheim Vetmedica Gmbh | Angiotensin II receptor antagonist for the treatment of systemic diseases in cats |
| US20080103118A1 (en) * | 2006-10-27 | 2008-05-01 | Iomedix Development International Srl | Composition for improving blood cholesterol levels |
| GB0624090D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amine salts |
| GB0624084D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amino acid salts |
| GB0624087D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril combination salt |
| EP1970053A1 (en) * | 2007-03-14 | 2008-09-17 | Boehringer Ingelheim Pharma GmbH & Co. KG | Pharmaceutical composition |
| PL382311A1 (pl) * | 2007-04-27 | 2008-11-10 | Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna | Kompozycja farmaceutyczna o polepszonej stabilności zawierająca inhibitor acetylocholinoesterazy lub farmaceutycznie dopuszczalną jego sól oraz sposób jej wytwarzania |
| US20090060983A1 (en) * | 2007-08-30 | 2009-03-05 | Bunick Frank J | Method And Composition For Making An Orally Disintegrating Dosage Form |
| WO2009058950A2 (en) * | 2007-10-30 | 2009-05-07 | Dr. Reddy's Laboratories Ltd. | Pharmaceutical formulations comprising telmisartan and hydrochlorothiazide |
| CA2704209C (en) * | 2007-10-31 | 2017-02-28 | Mcneil-Ppc, Inc. | Orally disintegrative dosage form |
| EP2252273B1 (en) | 2008-03-19 | 2016-12-28 | ratiopharm GmbH | Solid pharmaceutical composition comprising a non-peptide angiotensin ii receptor antagonist and a diuretic |
| US10046081B2 (en) | 2008-04-11 | 2018-08-14 | The Henry M Jackson Foundation For The Advancement Of Military Medicine, Inc. | Electrospun dextran fibers and devices formed therefrom |
| DK2432452T3 (en) | 2009-05-20 | 2016-10-10 | Boehringer Ingelheim Vetmedica Gmbh | Pharmaceutically telmisartan drink solution |
| US8343533B2 (en) * | 2009-09-24 | 2013-01-01 | Mcneil-Ppc, Inc. | Manufacture of lozenge product with radiofrequency |
| US20110318411A1 (en) * | 2010-06-24 | 2011-12-29 | Luber Joseph R | Multi-layered orally disintegrating tablet and the manufacture thereof |
| RU2479310C2 (ru) * | 2011-02-09 | 2013-04-20 | Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") | Фармацевтическая композиция для лечения артериальной гипертензии и застойной сердечной недостаточности и способ ее получения |
| CN102885789A (zh) * | 2012-04-05 | 2013-01-23 | 常州制药厂有限公司 | 一种治疗高血压的复方制剂的制备方法 |
| US9233491B2 (en) | 2012-05-01 | 2016-01-12 | Johnson & Johnson Consumer Inc. | Machine for production of solid dosage forms |
| US9511028B2 (en) | 2012-05-01 | 2016-12-06 | Johnson & Johnson Consumer Inc. | Orally disintegrating tablet |
| US9445971B2 (en) | 2012-05-01 | 2016-09-20 | Johnson & Johnson Consumer Inc. | Method of manufacturing solid dosage form |
| JP6018420B2 (ja) * | 2012-06-05 | 2016-11-02 | ニプロ株式会社 | アンジオテンシンｉｉ受容体拮抗薬およびサイアザイド系利尿薬を含む医薬組成物 |
| EP3091966B1 (en) | 2014-01-10 | 2019-07-31 | Johnson & Johnson Consumer Inc. | Process for making tablet using radiofrequency and lossy coated particles |
| EP2979691A1 (en) * | 2014-07-30 | 2016-02-03 | Boehringer Ingelheim International GmbH | Oral disintegrating tablet |
| CR20180030A (es) * | 2015-06-26 | 2018-05-24 | Abbvie Inc | Composiciones farmacéuticas sólidas para el tratamiento del vhc. |
| HK1255203A1 (zh) * | 2015-07-17 | 2019-08-09 | Abbvie Inc. | 用於治疗hcv的固体药物组合物 |
| CA3004734A1 (en) | 2015-11-12 | 2017-06-18 | St. Teresa Medical, Inc. | A method of sealing a durotomy |
| US10493026B2 (en) | 2017-03-20 | 2019-12-03 | Johnson & Johnson Consumer Inc. | Process for making tablet using radiofrequency and lossy coated particles |
| WO2019089717A1 (en) | 2017-11-02 | 2019-05-09 | St. Teresa Medical, Inc. | Fibrin sealant products |
| WO2020109319A1 (en) | 2018-11-27 | 2020-06-04 | Zaklady Farmaceutyczne Polpharma S.A | Pharmaceutical composition comprising ramipril and indapamide |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW483763B (en) * | 1994-09-02 | 2002-04-21 | Astra Ab | Pharmaceutical composition comprising of ramipril and dihydropyridine compound |
| DE4446468A1 (de) * | 1994-12-23 | 1996-06-27 | Basf Ag | Verfahren zur Herstellung von umhüllten Tabletten |
| US6087386A (en) * | 1996-06-24 | 2000-07-11 | Merck & Co., Inc. | Composition of enalapril and losartan |
| WO2000027397A1 (en) * | 1998-11-06 | 2000-05-18 | Glaxo Group Limited | Antihypertensive medicaments containing lacidipine and telmisartan |
| GB0020691D0 (en) * | 2000-08-22 | 2000-10-11 | Boehringer Ingelheim Pharma | Pharmaceutical combination |
| PL366419A1 (en) * | 2000-08-22 | 2005-01-24 | Boehringer Ingelheim Pharma Bmbh & Co.Kg | Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors |
| US20030091630A1 (en) * | 2001-10-25 | 2003-05-15 | Jenny Louie-Helm | Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data |
| JP2003144528A (ja) * | 2001-11-15 | 2003-05-20 | Fancl Corp | 多層錠及びその製造方法 |
-
2004
- 2004-02-20 DE DE102004008804A patent/DE102004008804A1/de not_active Withdrawn
-
2005
- 2005-02-10 US US11/056,081 patent/US20050186274A1/en not_active Abandoned
- 2005-02-15 AU AU2005215115A patent/AU2005215115A1/en not_active Abandoned
- 2005-02-15 CA CA002552902A patent/CA2552902A1/en not_active Abandoned
- 2005-02-15 MX MXPA06008225A patent/MXPA06008225A/es unknown
- 2005-02-15 KR KR1020067019409A patent/KR20060130671A/ko not_active Withdrawn
- 2005-02-15 CN CNA2005800052700A patent/CN1921840A/zh active Pending
- 2005-02-15 JP JP2006553509A patent/JP2007523112A/ja active Pending
- 2005-02-15 EP EP05707394A patent/EP1718281A1/en not_active Withdrawn
- 2005-02-15 BR BRPI0507887-3A patent/BRPI0507887A/pt not_active IP Right Cessation
- 2005-02-15 WO PCT/EP2005/001498 patent/WO2005079762A1/en not_active Ceased
- 2005-02-15 RU RU2006133453/15A patent/RU2006133453A/ru not_active Application Discontinuation
- 2005-02-17 UY UY28753A patent/UY28753A1/es not_active Application Discontinuation
- 2005-02-18 PE PE2005000192A patent/PE20051127A1/es not_active Application Discontinuation
- 2005-02-18 AR ARP050100579A patent/AR047806A1/es unknown
- 2005-02-18 TW TW094104757A patent/TW200533389A/zh unknown
-
2006
- 2006-06-14 ZA ZA200604913A patent/ZA200604913B/en unknown
- 2006-08-17 IL IL177536A patent/IL177536A0/en unknown
- 2006-08-21 EC EC2006006779A patent/ECSP066779A/es unknown
- 2006-09-06 NO NO20063997A patent/NO20063997L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2005215115A1 (en) | 2005-09-01 |
| MXPA06008225A (es) | 2006-08-31 |
| CN1921840A (zh) | 2007-02-28 |
| EP1718281A1 (en) | 2006-11-08 |
| UY28753A1 (es) | 2005-09-30 |
| IL177536A0 (en) | 2006-12-10 |
| BRPI0507887A (pt) | 2007-08-07 |
| AR047806A1 (es) | 2006-02-22 |
| ECSP066779A (es) | 2006-12-20 |
| JP2007523112A (ja) | 2007-08-16 |
| RU2006133453A (ru) | 2008-03-27 |
| WO2005079762A1 (en) | 2005-09-01 |
| TW200533389A (en) | 2005-10-16 |
| ZA200604913B (en) | 2007-11-28 |
| US20050186274A1 (en) | 2005-08-25 |
| KR20060130671A (ko) | 2006-12-19 |
| CA2552902A1 (en) | 2005-09-01 |
| PE20051127A1 (es) | 2006-01-31 |
| DE102004008804A1 (de) | 2005-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20063997L (no) | Tablett med flere lag | |
| NO20071375L (no) | Bilags tablett. | |
| NO20071514L (no) | Tolags tablett inneholdende Telmisartan og Amlodipin | |
| IL194933A0 (en) | A method for the preparation of amorphous telmisartane | |
| WO2009058950A3 (en) | Pharmaceutical formulations comprising telmisartan and hydrochlorothiazide | |
| DE122012000018I1 (de) | Benzimidazolderivate und ihre verwendung als antagonisten des a II rezeptors. | |
| JO3492B1 (ar) | تركيبات صيدلانية من مضاد مستقبل أنجيوتنسين ومثبط nep | |
| CL2007003613A1 (es) | Compuestos nitroderivados, antagonistas del receptor de angiotensina ii; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar hipertension. | |
| WO2005011652A3 (en) | Use of a vitamin d receptor activator or a vitamin d analog to treat kidney disease | |
| ECSP066727A (es) | Reacciones de acoplamiento útiles en la preparación de derivados de (1h-tetrazol-5-il)-bifenilo | |
| DK1553944T3 (da) | Farmaceutisk præparat, hvori kombineres tenatoprazol og en histamin-H2-receptorantagonist | |
| TH79790A (th) | ยาเม็ดชนิดสองชั้น | |
| WO2007017469A3 (en) | Process for preparing an angiotensin ii receptor antagonist | |
| DK1919483T3 (da) | Kombinationspræparat af et thiazidiuretikum og et loop-diuretikum | |
| TH79244A (th) | ยาเม็ดแบบมีสองชั้น |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |